Study Title: A Phase 3, Single-arm, Multicenter Study to Evaluate the Efficacy and Safety of UGN-104, a Novel Formulation of UGN-101, for the Treatment of Patients With Low-Grade Upper Tract Urothelial Cancer (LG-UTUC)
For more information about the trial above please contact the study team:Medical University of South CarolinaPrincipal Investigator, Tsivian, Matvey, at tsivian@musc.edu.Study Coordinator, Tucker, Renee, at tuckerr@musc.edu.Trial opened at the following institutions: Medical University of South Carolina